Skip to main content

Gene Abnormality clinical trials at UCSF

1 research study open to eligible people

Gene abnormality is when there's a problem with a person's DNA that can lead to health issues. UCSF is recruiting participants for a clinical trial called "Neonatal Seizure Registry, Genetics of Post-Neonatal Epilepsy." This study is for parent-child trios from the Neonatal Seizure Registry to learn more about gene abnormalities and their relationship to epilepsy.

Showing trials for
  • Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

    open to all eligible people

    The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seizures. The researchers aim to develop prediction rules to stratify neonates into low, medium, and high risk for post-neonatal epilepsy based on clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and genetic risk factors.

    San Francisco, California and other locations

Our lead scientists for Gene Abnormality research studies include .

Last updated: